.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Harvard Business School
Cerilliant
Federal Trade Commission
Dow
Johnson and Johnson
Queensland Health
Boehringer Ingelheim
McKesson
US Army

Generated: July 20, 2017

DrugPatentWatch Database Preview

PLATINOL-AQ Drug Profile

« Back to Dashboard

What is the patent landscape for Platinol-aq, and when can generic versions of Platinol-aq launch?

Platinol-aq is a drug marketed by Hq Spclt Pharma and is included in one NDA.

The generic ingredient in PLATINOL-AQ is cisplatin. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cisplatin profile page.

Summary for Tradename: PLATINOL-AQ

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list22
Clinical Trials: see list12
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PLATINOL-AQ at DailyMed

Pharmacology for Tradename: PLATINOL-AQ

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hq Spclt Pharma
PLATINOL-AQ
cisplatin
INJECTABLE;INJECTION018057-003Jul 18, 1984DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PLATINOL-AQ

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hq Spclt Pharma
PLATINOL-AQ
cisplatin
INJECTABLE;INJECTION018057-003Jul 18, 19844,177,263► Subscribe
Hq Spclt Pharma
PLATINOL-AQ
cisplatin
INJECTABLE;INJECTION018057-003Jul 18, 19845,562,925► Subscribe
Hq Spclt Pharma
PLATINOL-AQ
cisplatin
INJECTABLE;INJECTION018057-003Jul 18, 19844,310,515► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Colorcon
Covington
QuintilesIMS
Fuji
Mallinckrodt
Daiichi Sankyo
Healthtrust
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot